Regenerative Medicine Market Is Predicted To Grow Swiftly Due To Increased Prevalence Of Neurodegenerative, Orthopedic, And Other Aging-Related Disorders Till 2025: Grand View Research, Inc.
The
global regenerative medicine market size is expected to
reach USD 5.59 billion by 2025, according to a new report by Grand View
Research, Inc. Increased prevalence of neurodegenerative, orthopedic, and other
aging-related disorders in geriatric population coupled with rising global
geriatric population is anticipated to drive market growth.
Developments
in biotechnology have enabled gaining in-depth knowledge pertaining to cell
division and differentiation as well as the metabolism mechanism of various
cells. This enriched knowledge, coupled with emergence of novel streams of
biotechnology such as gene therapy and nanotechnology, further prospered use of
cell-based technology in therapeutic treatment.
Well
established regenerative approached for various dermatological indications
exists since ages. Technological advances introduced scaffolds, matrices, and
grafts engineered for faster regeneration and minimal surgical procedure.
Identification
of ability of stem cells to develop into various different cell lines further
propelled the advancements in regenerative medicine. Frequent media exposure
due to regulatory as well as ethical controversies around embryonic stem cells
has increased awareness among the masses. This encouraged researchers to
explore and develop other potential fields for similar applications, such as
induced pluripotent stem cells (iPSC).
Furthermore,
the emergence of gene therapy techniques with potential to rectify and restore
effects of gene mutations in cells is under development. Conditions caused due
to Single Nucleotide Polymorphism (SNP) as well as mutations that induce
degenerative characteristics are primarily targeted.
Biologics,
individually or in combination with cells or devices, are explored to support
regenerate the biological functions of cells, tissues, or organs. A number of
combinatorial therapies to support chemotherapy and other cancer treatments by
prevention as well as treatment for cancer relapse are in development phases.
In
addition, rising prevalence of complicated degenerative disorders such as
age-related macular degeneration, Alzheimer’s disease, and Parkinson’s disease,
especially in the aging population resulted in high investments in R&D to
develop therapeutic solutions.
Regenerative
medicine grabs the attention of the healthcare industry owing to its promising
applications along with significant advances in supportive fields including
tissue engineering, stem cells, gene therapy, drug discovery and
nanotechnology. For instance, 3D printing over scaffold with stem cells to
restore structure as well as functional characteristics of biological cells,
tissues, and organs.
UK
regenerative medicine market revenue by product type, 2014 - 2025 (USD Million)
Browse full research report on Regenerative
Medicine Market: http://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market
Further
Key Findings From the Study Suggest:
- The global regenerative medicine demand
exceeded USD 1.7 billion in 2016 and is expected to grow at a considerable
rate over the forecast period owing to the presence of a strong looking
product pipeline with anticipated commercializations just around the corner
- Therapeutics emerged as the largest product
segment in 2016 as it has a relatively high implementation and usage rate
resulting in higher adoption
- Global regenerative services demand for
facilities such as tissue banks and cellular engineering tools is expected
to drive demand in the segment
- The industry in Asia Pacific is projected to
witness substantial growth over the next decade owing to various
developments across major economies with increased focus of dominant
players in emerging economies is attributive to market growth. market.
- Key players including Asterias Bio, Athersys,
Integra LifeSciences Corpotation, and MiMedx are involved in complex
technical cum financial partnerships with larger players in an attempt to
expedite R&D
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-regenerative-medicine-market
About
Grand View Research, Inc:
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, the company offers market intelligence studies
ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
Comments
Post a Comment